Natural peptide analgesics: The role of solution conformation

Cellular and Molecular Life Sciences

Volumn 58, Issue 11, 2001, Pages 1572-1582

  Spadaccini, R ^a   Temussi, P A ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Biomimetic environment; Conformation; NMR; Opioid; Osmolyte; Peptide

Indexed keywords

ANALGESIC AGENT; ENKEPHALIN; OPIATE; OPIATE AGONIST; OPIATE RECEPTOR; PEPTIDE;

ANALGESIC ACTIVITY; DRUG DESIGN; DRUG RECEPTOR BINDING; HUMAN; NONHUMAN; PROTEIN STRUCTURE; REVIEW; SPECTROSCOPY;

EID: 0034776780     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00000797     Document Type: Review

References (101)

1. A molecular basis for opiate action
2. Identification of two related pentapeptides from the brain with potent opiate agonist activity
3. The effects of morphine- and morphinelike drugs in the non-dependent and morphine-dependent chronic spinal dog
4. Prediction of potency and receptor selectivity of regulatory peptides: The membrane compartment concept
5. Recent developments in the design of receptor specific opioid peptides
6. The brain-gut-skin triangle: New peptides
7. D-alanine in the frog skin peptide dermorphin is derived from L-alanine in the precursor
8. Deltorphin, a novel amphibian skin peptide with high selectivity and affinity for delta opioid receptors
9. Deltorphins: A family of naturally occurring peptides with high affinity and selectivity for delta opioid binding sites
10. A 500 MHz study of μ opioid peptides in a simulated receptor environment
11. SAR of tetrapeptides related to dermorphin
12. Conformational properties of deltorphin
13. New features of the δ opioid receptor: Conformational properties of deltorphin I analogues
14. Conformational analysis of an opioid peptide in solvent media that mimic cytoplasm viscosity
15. Solution structure of deltorphin I at 265 K: A quantitative NMR study
16. Opioid receptor three-dimensional structures from distance geometry calculations with hydrogen bonding constraints
17. Conformational analysis of potent and very selective δ opioid dipeptide antagonists
18. 15N-Leu-enkephalin
19. Role of aromatic transmembrane residues of the delta-opioid receptor in ligand recognition
20. Crystal structure of [Leu5] enkephalin
21. Crystal structure of leucine-enkephalin
22. New theoretical methodology for elucidating the solution structure of peptides from NMR data. 1. The relative contribution of low-energy microstates to the partition-function
23. X-ray diffraction studies of enkephalins: Crystal structure of [(4′-bromo) Phe4, Leu5] enkephalin
24. The crystal structures of [Met5] enkephalin and a third form of [Leu5]enkephalin: Observations of a novel pleated beta-sheet
25. Crystal structure of methionine-enkephalin
26. Crystal structure of an extended-conformation leucine-enkephalin dimer monohydrate
27. Crystal structures of [Met5] and [(4-bromo)Phe4, Met5]enkephalins: Formation of a dimeric antiparallel beta-structure
28. X-ray diffraction studies of enkephalins and opiates
29. A crystal molecular conformation of leucine-enkephalin related to the morphine molecule
30. Crystal structure of deltakephalin: A delta-selective opioid peptide with a novel beta-bend-like conformation
31. Conserved and novel structural characteristics of enantiomorphic Leu-enkephalin: X-ray crystal analysis of Leu-enkephalin enantiomer, L-Tyr-Gly-Gly-L-Phe-L-Leu and D-Tyr-Gly-Gly-D-Phe-D-Leu
32. [D-Ala2,D-Leu5]-enkephalin hydrochloride
33. Structural studies of opioid peptides: A review of recent progress in X-ray diffraction studies
34. Determination of the stable microstates of a peptide from NOE distance constraints and optimization of atomic solvation parameters
35. Stochastic exploration of molecular mechanics energy surfaces - Hunting for the global minimum
36. An unbounded systematic search of conformational space
37. Monte-Carlo-minimization approach to the multiple-minima problem in protein folding
38. Optimization by simulated annealing
39. Efficiency of simulated annealing for peptides with increasing geometrical restrictions
40. Algorithmic aspects of multicanonical simulations
41. Prediction of peptide conformation by multicanonical algorithm - New approach to the multiple-minima problem
42. Multicanonical procedure for continuum peptide models
43. The folding funnel landscape for the peptide Met-enkephalin
44. Coupling-constants as restraints in ensemble distance driven dynamics
45. Multiconformational peptide dynamics derived from NMR data: A new search algorithm and its application to antamanide
46. NMR analysis of molecular flexibility in solution: A new method for the study of complex distributions of rapidly exchanging conformations. Application to a 13-residue peptide with an 8-residue loop
47. Do NOE distances contain enough information to assess the relative populations of multi-conformer structures?
48. New theoretical methodology for elucidating the solution structure of peptides from NMR data. II. Free energy of dominant microstates of Leu-enkephalin and population-weighted average nuclear Overhauser effects intensities
49. New theoretical methodology for elucidating the solution structure of peptides from NMR data. 3. Solvation effects
50. Free energy based populations of interconverting microstates of a cyclic peptide lead to the experimental NMR data
51. Intermolecular potentials from crystal data. VI. Determination of empirical potentials for O-H=O=C hydrogen-bonds from packing configuration
52. Proton magnetic resonance studies of conformation and flexibility of enkephalin peptides
53. Conformation of Met5-enkephalin determined by high field PMR spectroscopy
54. Bioactive conformation of linear peptides in solution: An elusive goal?
55. Proton spinlattice relaxation studies of(D-Ala2-Met5) enkephalin
56. Structure determination of a tetrasaccharide: Transient nuclear Overhauser effects in the rotating frame
57. NOE in linear peptides: A low temperature 500 MHz study of Metenkephalin
58. NOE measurements on linear peptides in cryoprotective solvents
59. NOE data at 500 MHz reveal the proximity of phenyl and tyrosine rings in enkephalin
60. Proteins at work: 'Stop-action' pictures at subzero temperatures
61. Increased thermal stability of proteins in the presence of naturally occurring osmolytes
62. The use of osmolytes to facilitate protein NMR spectroscopy
63. Viscosity as a conformational sieve: NOE of linear peptides in cryoprotective mixtures
64. Relationschip of synthetic processes in the cell to cytoplasmic visocisity
65. Aqueous cytoplasm and cell membrane structures
66. Effects of unstirred layers on membrane phenomena
67. New insights on μ/δ selectivity of opioid peptides: Conformational analysis of deltorphin analogues
68. NMR studies of dermorphin and its peptide fragments
69. A conformational study of the opioid peptide dermorphin by 1D and 2D NMR spectroscopy
70. Role of membrane lipids in peptide hormone function: Binding of enkephalins to micelles
71. Preferred conformation of endomorphin-1 in aqueous and membrane-mimetic environments
72. NMR studies of the structure and dynamics of peptide E, an endogenous opioid peptide that binds with high affinity to multiple opioid receptor subtypes
73. Conformational preferences of [Leu5]enkephalin in biomimetic media: Investigation by 1H NMR
74. Opioid peptides in micellar systems: Conformational analysis by CD and by one-dimensional and two-dimensional 1H-NMR spectroscopy
75. Delta-opiate DPDPE in magnetically oriented phospholipid micelles: Binding and arrangement of aromatic pharmacophores
76. Structural model of a cyclic dynorphin A analog bound to dodecylphosphocholine micelles by NMR and restrained molecular dynamics
77. NMR and structural model of dynorphin A (1-17) bound to dodecylphosphocholine micelles
78. Role of tryptophan-14 in the interaction of dynorphin A(1-17) with micelles
79. Role of hydrophobic substituents in the interaction of opioid Tyr-Tic dipeptide analogs with dodecylphosphocholine micelles: Molecular partitioning in model membrane systems
80. The use of dodecylphosphocholine micelles in solution NMR
81. Solution conformation of mu-selective dermorphin and delta-selective deltorphin-I in phospholipid micelles, studied by NMR spectroscopy and molecular dynamics simulations
82. Estimated conformation, orientation, and accumulation of dynorphin A-(1-13)-tridecapeptide on the surface of neutral lipid membranes
83. Conformation of dynorphin A (1-17) bound to dodecylphosphocholine micelles
84. The structure of melittin: A 1H-NMR study in methanol
85. A two-dimensional NMR study of the antimicrobial peptide magainin 2
86. Effect of trifluoroethanol on protein secondary structure: An NMR and CD study using a synthetic actin peptide
87. Comparing conformations at low temperature and at high viscosity: Conformational study of somatostatin and two of its analogues in methanol and in ethylene glycol
88. Contribution of increased length and intact capping sequences to the conformational preference for helix in a 31-residue peptide from the C terminus of myohemerythrin
89. Teflon-coated peptides: Hexafluoroacetone trihydrate as a structure stabilizer for peptides
90. Solution structure of dynorphin A (1-17): A NMR study in a cryoprotective mixture at 278 K
91. Solution structure of human β-endorphin in helicogenic solvents: A NMR study
92. Solution conformation of the synthetic bovine proenkephalin-A209-237 by 1H NMR spectroscopy
93. Proton NMR and CD solution conformation determination and opioid receptor binding studies of a dynorphin A (1-17) model peptide
94. 1H nuclear magnetic resonance study of the opioid peptide dynorphin-(1-13) in aqueous solution
95. Mimicking the membrane-mediated conformation of dynorphin A (1-13) peptide: Circular dichroism and nuclear magnetic resonance studies in methanolic solution
96. Dynorphin-(1-13), an extraordinarily potent opioid peptide
97. The C-terminal bisphosphorylated proenkephalin-A-(209-237)-peptide from adrenal medullary chromaffin granules possesses antibacterial activity
98. Models of antagonism: Design and solution structure of a partially rigid opioid antagonist lacking the basic center
99. An experimental attempt of simulating receptor site environment
100. 3
101. Turns in peptides and proteins